Oak Street Health (OSH) Scheduled to Post Quarterly Earnings on Tuesday

Oak Street Health (NYSE:OSHGet Rating) will issue its quarterly earnings data after the market closes on Tuesday, May 3rd. Analysts expect the company to announce earnings of ($0.38) per share for the quarter. Oak Street Health has set its Q1 2022 guidance at EPS and its FY 2022 guidance at EPS.Persons that wish to register for the company’s earnings conference call can do so using this link.

Oak Street Health (NYSE:OSHGet Rating) last released its quarterly earnings results on Monday, February 28th. The company reported ($0.62) earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.59) by ($0.03). The company had revenue of $394.10 million during the quarter, compared to analyst estimates of $389.79 million. Oak Street Health had a negative net margin of 28.57% and a negative return on equity of 231.28%. The firm’s quarterly revenue was up 58.5% compared to the same quarter last year. During the same quarter last year, the company earned ($0.40) EPS. On average, analysts expect Oak Street Health to post $-2 EPS for the current fiscal year and $-2 EPS for the next fiscal year.

Oak Street Health stock opened at $21.33 on Tuesday. The stock has a market capitalization of $5.14 billion, a PE ratio of -11.59 and a beta of 2.18. Oak Street Health has a twelve month low of $13.72 and a twelve month high of $65.22. The company has a quick ratio of 2.06, a current ratio of 2.06 and a debt-to-equity ratio of 16.10. The company has a 50 day moving average of $22.68 and a 200-day moving average of $28.44.

Several research firms have recently weighed in on OSH. Morgan Stanley upped their price target on shares of Oak Street Health from $18.00 to $19.00 and gave the company an “equal weight” rating in a report on Wednesday, March 2nd. UBS Group began coverage on shares of Oak Street Health in a report on Wednesday, April 20th. They issued a “neutral” rating and a $26.00 price target for the company. Zacks Investment Research upgraded shares of Oak Street Health from a “sell” rating to a “hold” rating in a report on Saturday, March 5th. SVB Leerink increased their target price on shares of Oak Street Health from $17.00 to $23.00 and gave the stock a “market perform” rating in a report on Wednesday, March 2nd. Finally, Truist Financial reduced their target price on shares of Oak Street Health from $45.00 to $34.00 in a report on Wednesday, January 19th. Five analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company. According to data from MarketBeat.com, Oak Street Health presently has an average rating of “Buy” and an average price target of $39.79.

In other Oak Street Health news, COO Brian Clem sold 15,000 shares of the stock in a transaction on Thursday, February 17th. The shares were sold at an average price of $16.44, for a total value of $246,600.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, insider Geoffrey M. Price sold 60,000 shares of the stock in a transaction on Tuesday, April 5th. The shares were sold at an average price of $26.56, for a total transaction of $1,593,600.00. Following the completion of the sale, the insider now owns 3,871,377 shares of the company’s stock, valued at approximately $102,823,773.12. The disclosure for this sale can be found here. In the last quarter, insiders sold 233,271 shares of company stock valued at $5,695,945. Corporate insiders own 11.40% of the company’s stock.

Institutional investors and hedge funds have recently modified their holdings of the company. Canada Pension Plan Investment Board bought a new position in shares of Oak Street Health in the fourth quarter valued at about $46,000. NEXT Financial Group Inc raised its position in shares of Oak Street Health by 14.0% in the fourth quarter. NEXT Financial Group Inc now owns 6,819 shares of the company’s stock valued at $226,000 after purchasing an additional 837 shares during the period. LPL Financial LLC raised its position in shares of Oak Street Health by 28.1% in the third quarter. LPL Financial LLC now owns 6,368 shares of the company’s stock valued at $271,000 after purchasing an additional 1,398 shares during the period. Amalgamated Bank raised its position in shares of Oak Street Health by 43.3% in the fourth quarter. Amalgamated Bank now owns 8,848 shares of the company’s stock valued at $293,000 after purchasing an additional 2,674 shares during the period. Finally, MML Investors Services LLC raised its position in shares of Oak Street Health by 7.6% in the fourth quarter. MML Investors Services LLC now owns 9,433 shares of the company’s stock valued at $313,000 after purchasing an additional 665 shares during the period. 86.15% of the stock is currently owned by institutional investors.

About Oak Street Health (Get Rating)

Oak Street Health, Inc, together with its subsidiaries, offers healthcare services to the patients in the United States. The company operates primary care centers for Medicare beneficiaries. As of December 31, 2021, it operated 129 centers in 19 states, including Illinois, Michigan, Pennsylvania, Ohio, and Texas.

See Also

Earnings History for Oak Street Health (NYSE:OSH)

Receive News & Ratings for Oak Street Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oak Street Health and related companies with MarketBeat.com's FREE daily email newsletter.